Abstract
New ways of treating insulin-dependent diabetes mellitis (IDDM) may help to prevent the insurgence of late diabetic complications associated with this condition. One approach involves immunointervention at the time of clinical diagnosis, with the aim of maintaining some residual β cell function. Research is also progressing in the field of islet transplantation, following significant developments in animal models.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
